Healthcare · Healthcare Services
QVM read Quality business Quality Strong, Valuation Expensive, Momentum Neutral
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Ranks #25 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 10 Mar 2026 | Jagadeesh Kodali | Other | Sell | 0 | ₹0 |
| 11 Aug 2025 | Harriman Vungal | Promoter | Sell | 0 | ₹0 |
| 2 Jul 2025 | Harriman Vungal | Promoter | Sell | 0 | ₹0 |
| 2 Jul 2025 | Sudheshna Vungal | Promoter group | Buy | 0 | ₹0 |
| 2 Jul 2025 | Sireesh Chandra Vungal | Promoter group | Buy | 0 | ₹0 |
| 2 Jul 2025 | Vungal Rajeswari | Promoter group | Buy | 0 | ₹0 |
| 2 Jun 2025 | VASIREDDI VEERABHADRA PRASAD | Promoter | Sell | 0 | ₹0 |
| 2 Jun 2025 | SUJANI VASIREDDI | Promoter group | Buy | 0 | ₹0 |
| 2 Jun 2025 | RAJYA LAKSHMI VASIREDDI | Promoter group | Buy | 0 | ₹0 |
| 17 Feb 2025 | Harriman Vungal | Promoter | Sell | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 3 Sep 2025 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Buy | 264,357 | 807.0300 | BSE |
| 3 Sep 2025 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 264,357 | 807.3000 | BSE |
| 3 Sep 2025 | HRTI PRIVATE LIMITED | Bulk | Buy | 291,186 | 806.1800 | BSE |
| 3 Sep 2025 | HRTI PRIVATE LIMITED | Bulk | Sell | 307,820 | 807.4500 | BSE |
| 13 Aug 2025 | HRTI PRIVATE LIMITED | Bulk | Sell | 243,239 | 641.0600 | NSE |
| 13 Aug 2025 | HRTI PRIVATE LIMITED | Bulk | Buy | 231,187 | 638.1500 | NSE |
| 7 Aug 2025 | QE SECURITIES LLP | Bulk | Sell | 321,542 | 649.1400 | NSE |
| 7 Aug 2025 | QE SECURITIES LLP | Bulk | Buy | 316,074 | 649.1300 | NSE |
| 7 Aug 2025 | JUNOMONETA FINSOL PRIVATE LIMITED | Bulk | Sell | 223,391 | 646.7400 | NSE |
| 7 Aug 2025 | JUNOMONETA FINSOL PRIVATE LIMITED | Bulk | Buy | 223,391 | 646.2100 | NSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| 18 Jun 2026 | Dividend - Rs 2 Per Share | 2.0000 | 18 Jun 2026 |
| 30 May 2025 | Dividend - Rs 2 Per Share | 2.0000 | 30 May 2025 |
| 11 Jul 2024 | Annual General Meeting/Dividend - Rs 2 Per Share | 2.0000 | — |
| 21 Jun 2023 | Annual General Meeting/Dividend - Rs 2 Per Share | 2.0000 | — |
| 16 Jun 2022 | Annual General Meeting/Dividend - Rs 2 Per Share | 2.0000 | — |
| 25 Jun 2021 | Annual General Meeting/Dividend - Rs 2 Per Share | 2.0000 | — |
| 18 Jul 2019 | Annual General Meeting/Dividend - Rs 2 Per Share | 2.0000 | — |
| 14 Aug 2018 | Annual General Meeting/Dividend- Rs 2 Per Share | 2.0000 | — |
| 25 Aug 2016 | Annual General Meeting/Dividend Re 1/- Per Share | 1.0000 | — |
| 6 Aug 2015 | Annual General Meeting/Dividend - Re 1/- Per Share | 1.0000 | — |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| 13 Jun 2025 | BONUS | Bonus 1:1 |
| 1 Sep 2020 | OTHER | Annual General Meeting |
| 19 Sep 2017 | OTHER | Annual General Meeting |
| 6 Sep 2012 | OTHER | Annual General Meeting |
| 10 Sep 2009 | OTHER | Ann Clsng/Dv-Re.0.80 P Sh |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 20 Jul 2026 | Financial Results | Yes |
| 6 May 2026 | Financial Results/Dividend | Yes |
| 28 Jan 2026 | Financial Results | Yes |
| 3 Nov 2025 | Financial Results | Yes |
| 17 Jul 2025 | Financial Results | Yes |
Exchange disclosures (NSE and BSE), most recent first.
| Date | Category | Announcement |
|---|---|---|
| 30 Sep 2026 | Trading Window | Vimta Labs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 30 Sep 2026 | Insider Trading / SAST | Vimta Labs Ltd-$ - 524394 - Closure of Trading Window |
| 16 Sep 2026 | Company Update | Vimta Labs Ltd-$ - 524394 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
| 16 Sep 2026 | Allotment of Securities | Vimta Labs Limited has informed the Exchange regarding allotment of 12955 securities pursuant to ESOP/ESPS at its meeting held on September 16, 2026 |
| 8 Sep 2026 | Company Update | Vimta Labs Ltd-$ - 524394 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| 8 Sep 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Vimta Labs Limited has informed the Exchange about Schedule of meet |
| 2 Sep 2026 | Credit Rating | Vimta Labs Limited has informed the Exchange about Credit Rating |
| 31 Aug 2026 | Spurt in Volume | Significant increase in volume has been observed in Vimta Labs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Vimta Labs Limited has submitted their response. |
| 31 Aug 2026 | Spurt in Volume | Significant increase in volume has been observed in Vimta Labs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. |
| 29 Aug 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Vimta Labs Limited has informed the Exchange about Schedule of meet |
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
